Literature DB >> 21785324

Dermatofibrosarcoma protuberans treated with wide local excision and followed at a cancer hospital: prognostic significance of clinicopathologic variables.

Ozlem Erdem1, Angela J Wyatt, E Lin, Xuemei Wang, Victor G Prieto.   

Abstract

Dermatofibrosarcoma protuberans (DFSP) is a relatively rare low-grade sarcoma. Local control can usually be achieved by wide local excision, but some patients still develop recurrences. The aim of this study was to investigate the correlation between clinicopathologic factors and recurrence-free survival (RFS)/overall survival (OS) in a large series of DFSP patients from a single institution. The study group included sections and medical records of 122 patients (63 women and 59 men, median age of 43) with primary DFSP from UT-MD Anderson Cancer Center between 1976 and 2005. Fibrosarcomatous change was detected in 24 (20.9%) patients. Thirty-eight of 120 patients (31.7%) recurred with a median RFS of 10.2 years. The 5-year RFS rate was 64.2%. Based on univariate analyses, fibrosarcomatous change, mitotic count, metastasis at time of diagnosis, and acral location were significantly associated with shorter RFS. On multivariate analysis, acral location and fibrosarcomatous change remained significant for shorter RFS. Five-year OS was 95.5% (95% confidence interval: 75.42%-99.3%). On univariate analysis, mitotic count per square millimeter, presence of necrosis, and metastasis at time of diagnosis were significantly associated with lower OS. On multivariate analysis, only presence of metastasis remained significantly associated with shorter OS. DFSP-FS variant and acral site are associated with shorter recurrence-free interval after wide local excision. Therefore, patients with tumors on acral sites or those with a fibrosarcomatous component may benefit from aggressive therapies other than wide local excision. The only factor that remains significantly associated with decreased OS is detection of metastasis.

Entities:  

Mesh:

Year:  2012        PMID: 21785324     DOI: 10.1097/DAD.0b013e3182120671

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  6 in total

1.  CDKN2A/p16 Loss Implicates CDK4 as a Therapeutic Target in Imatinib-Resistant Dermatofibrosarcoma Protuberans.

Authors:  Grant Eilers; Jeffrey T Czaplinski; Mark Mayeda; Nacef Bahri; Derrick Tao; Meijun Zhu; Jason L Hornick; Neal I Lindeman; Ewa Sicinska; Andrew J Wagner; Jonathan A Fletcher; Adrian Mariño-Enriquez
Journal:  Mol Cancer Ther       Date:  2015-04-07       Impact factor: 6.261

2.  Clinicopathological features of dermatofibrosarcoma protuberans.

Authors:  Noppadol Larbcharoensub; Jitchai Kayankarnnavee; Suda Sanpaphant; Kidakorn Kiranantawat; Chewarat Wirojtananugoon; Vorachai Sirikulchayanonta
Journal:  Oncol Lett       Date:  2015-11-24       Impact factor: 2.967

3.  Dermatofibrosarcoma protuberans with pit-like lesions: A case report and literature review.

Authors:  Jinjing Jia; Yan Zheng; Xinyu Dong; Xin Wang; Jiao Yang; Zhaoxia Ying; Yongxian Wang; Xinwu Niu; Shengxiang Xiao
Journal:  Oncol Lett       Date:  2015-09-24       Impact factor: 2.967

4.  Dermatofibrosarcoma protuberans of the hallux: A case report with review of the literature.

Authors:  Rafik Elafram; Majdi Ben Romdhane; Nayssem Khessairi; Majdi Sghaier; Hedi Annabi
Journal:  Int J Surg Case Rep       Date:  2022-06-22

5.  Dermatofibrosarcoma protuberans, a rare but locally aggressive tumor on finger: clinical and aeromedical considerations.

Authors:  Kwo-Tsao Chiang; Shih-Yu Lee; Hsin Chu
Journal:  Case Reports Plast Surg Hand Surg       Date:  2015-01-06

6.  Unmasking dermatofibrosarcoma protuberans: Case report of an atypical presentation complicated by post-surgical excision.

Authors:  YaQun Zhou Arlene; Justin Chin; Millard D Strutin; Christine M Lomiguen
Journal:  Int J Surg Case Rep       Date:  2020-04-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.